SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Financial Collapse of 2001 Unwinding
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kingfisher who wrote (7619)12/15/2021 2:35:39 AM
From: elmatador1 Recommendation

Recommended By
kingfisher

   of 13796
 
UK just removed the travel ban on 11 African countries.


Let's watch the vaccine stocks' debacle once EU and US remove the travel bans too.


That pulls the floor under the vaccine stocks that got a boost on "Omicron concerns"

Vaccine makers were betting on an "Omicron concerns"

The whole vaccine circus assembled collpases as there is no more room to vaccinate people.
  • People who needed a vaccinae are long ago vaccinated.
  • People who thought they need the shot idem
  • After all that, the Law of the Big Numbers kicks in: For every new shot sold there is a huge effort just to sell a shot. No longer worse the effort

Covid vaccine makers' stocks soar on Omicron variant concerns



By Paul R. La Monica, CNN Business

Updated 1947 GMT (0347 HKT) November 29, 2021

Fears about the Omicron variant of Covid-19 rattled the world's financial markets Friday and early Monday morning. But shares of the major coronavirus vaccine makers were getting a boost from the latest pandemic jitters.

Moderna ( MRNA) soared more than 20% during Black Friday's abbreviated session of trading on Wall Street and were up another 10% Monday, too.
BioNTech ( BNTX) surged 14% Friday and were up 3% Monday while the European drug maker's vaccine partner, Big Pharma leader Pfizer ( PFE), gained 6% Friday but fell a bit Monday.

Shares of Novavax ( NVAX), another company that is seeking approval from the United States' Food and Drug Administration for its Covid vaccine, were up 9% Friday but gave back a big chunk of those gains Monday, falling 8%.

The stocks of two other vaccine manufacturers — Johnson & Johnson ( JNJ) and AstraZeneca ( AZN) — moved only modestly Friday and Monday.

Investors are hoping that the major vaccine makers will be able to quickly update their Covid vaccines so that it can offer protection for the Omicron variant.

Moderna said Friday that it "will rapidly advance an Omicron-specific booster candidate" while Pfizer has stressed that it could hopefully have an update of its vaccine ready in 100 days if Omicron proves to be resistant to its current vaccine.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News